BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
TIXiMED
/
Anath Shalev, MD
AS
Anath Shalev, MD
Founder, Chief Scientific Officer, Chief Medical Officer
TIXiMED
Therapeutic Areas
Type 1 Diabetes
Type 2 Diabetes
MASLD/MASH
TIXiMED Pipeline
Drug
Indication
Phase
TIX100
Type 1 Diabetes, Type 2 Diabetes, MASLD/MASH
Phase 1
Leadership Team at TIXiMED
SD
Stephen Daly
Chief Executive Officer & Chief Financial Officer
TM
T. Michael Goodrich, II, JD
President, Executive Board Chair, General Counsel
View full TIXiMED profile